Skip to content

Posts tagged ‘HER2-Positive’

0April 6, 2013Biomarker Analysis Identified Women Most Likely to Benefit From T-DM1

2December 8, 2011Addition of Trastuzumab May Potentially Equalize Disease-Free Survival Outcomes Among Obese and Normal-Weight Patients

0December 7, 2011Addition of Bevacizumab to Conventional Therapy Improved Progression-Free Survival in HER2-Positive Breast Cancer

0December 7, 2011Dual HER2 Blockade Significantly Extends Progression-Free Survival

0December 10, 2010Combination Therapy Reduced HER2-positive Breast Cancers

0December 30, 2009SABCS 2009 Interview with Kimberly L. Blackwell, M.D

Categories
Categories
AACR on Twitter:
- Today, the @US_FDA granted accelerated approval to the targeted therapeutic futibatinib for certain adult patients… twitter.com/i/web/status/1… 16 hours ago
- September is #ChildhoodCancerAwarenessMonth. Child cancer survivors face long-term side effects from their treatmen… twitter.com/i/web/status/1… 16 hours ago
- Register by October 3 to get the lowest rate for the AACR Special Conference on Cancer Metastasis (November 14-17,… twitter.com/i/web/status/1… 17 hours ago
- The AACR-Exelixis Renal Cell Carcinoma Research Fellowship is a two-year grant of $120,000 to support postdoctoral… twitter.com/i/web/status/1… 17 hours ago
- Next-Generation Checkpoints Beyond PD-1 and CTLA-4: @EvanLipson, Zev Wainberg, and @RZappasodi will address this to… twitter.com/i/web/status/1… 18 hours ago
AACR Journal RSS Feeds
AACR News Feeds
- AACR News
- AACR Scientific Podcasts
Follow the AACR Online